A Single-Arm, Single-Center, Phase II Exploratory Study of Adbelimab in Combination with Targeted Therapy and Chemotherapy for the Conversion Therapy of Patients with Unresectable MSS Colorectal Cancer with Liver Metastases

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 6a1e20649535d2c69201b3de054248d5a11266c4
First added on: May 02, 2026